Zai Lab (ZLAB) Depreciation & Amortization (CF) (2018 - 2026)

Zai Lab (ZLAB) posted quarterly Depreciation & Amortization (CF) of $3.9 million for Q1 2026, up 14.05% year-on-year from $3.5 million in Q1 2025, and up 0.72% on a QoQ basis from $3.9 million in Q4 2025.

Zai Lab (ZLAB) Depreciation & Amortization (CF) (2018 - 2026) Analysis & Trends

Zai Lab (ZLAB) has reported Depreciation & Amortization (CF) for 9 consecutive years, with $3.9 million the latest figure, recorded in Q1 2026.

  • Quarterly Depreciation & Amortization (CF) rose 14.05% year-over-year to $3.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $15.5 million (up 25.96% YoY) and the FY2025 annual result came in at $15.0 million, up 26.6% from the prior year.
  • Depreciation & Amortization (CF) rose to $3.9 million in Q1 2026 per ZLAB's latest filing, from $3.9 million in the prior quarter.
  • Over the last five years, Depreciation & Amortization (CF) for ZLAB reached as high as $3.9 million in Q1 2026 and fell as low as $1.9 million in Q2 2022.
  • A 5-year average of $2.8 million and a median of $2.9 million in 2024 frame the typical range for Depreciation & Amortization (CF).
  • Annual changes were most pronounced in 2023 — Depreciation & Amortization (CF) fell 13.84% — and 2024, when it surged 49.69%.
  • Year by year, Depreciation & Amortization (CF) stood at $2.1 million in 2022, then advanced by 15.61% to $2.5 million in 2023, then gained by 23.3% to $3.0 million in 2024, then increased by 29.16% to $3.9 million in 2025, then advanced by 0.72% to $3.9 million in 2026.
  • According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $3.9 million, $3.9 million, and $3.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 196,658.72
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 41.14 Mn
4 NuCana 279.75 Bn 279.75 Bn - 91,781.47
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 55.90 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 123.20 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 2.20 Mn
10 Zai Lab 22.02 Bn 22.02 Bn 61.30 Mn 3.94 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 3.94 Mn
Mar 31, 2026 3.94 Mn
Dec 31, 2025 3.92 Mn
Dec 31, 2025 3.92 Mn
Sep 30, 2025 3.90 Mn
Sep 30, 2025 3.90 Mn
Jun 30, 2025 3.74 Mn
Jun 30, 2025 3.74 Mn
Mar 31, 2025 3.46 Mn
Mar 31, 2025 3.46 Mn
Dec 31, 2024 3.03 Mn
Dec 31, 2024 3.03 Mn
Sep 30, 2024 2.87 Mn
Sep 30, 2024 2.87 Mn
Jun 30, 2024 2.94 Mn
Jun 30, 2024 2.94 Mn
Mar 31, 2024 3.01 Mn
Mar 31, 2024 3.01 Mn
Dec 31, 2023 2.46 Mn
Dec 31, 2023 2.46 Mn